The role of oxidative stress in the toxicity induced by amyloid β-peptide in Alzheimer's disease

Progress in Neurobiology

Volumn 62, Issue 6, 2000, Pages 633-648

  Miranda, Soledad ^a   Opazo, Carlos ^a   Larrondo, Luis F ^a   Muñoz, Francisco J ^a   Ruiz, Francisca ^a   Leighton, Federico ^a   Inestrosa, Nibaldo C ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Alzheimer's disease; Amyloid; Antioxidants; Apoptosis; Estrogens; Microglia; Oxidative stress; RAGE

Indexed keywords

ALPHA TOCOPHEROL; AMYLOID BETA PROTEIN; ANTIOXIDANT; ASCORBIC ACID; CATALASE; ESTRADIOL; ESTROGEN; FREE RADICAL; HYDROQUINONE; LAZAROID; LIPID; MELATONIN; METAL; NUCLEIC ACID; PROTEIN; REACTIVE OXYGEN METABOLITE; RIFAMPICIN; SUPEROXIDE DISMUTASE;

ALZHEIMER DISEASE; APOPTOSIS; CELL DEATH; HOMEOSTASIS; HUMAN; HYPOTHESIS; MEMBRANE DAMAGE; MICROGLIA; NERVE CELL DEGENERATION; NERVE CELL MEMBRANE; NERVE CELL NECROSIS; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SENILE PLAQUE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; ANTIOXIDANTS; APOPTOSIS; CELL DEATH; HUMANS; MEMBRANE LIPIDS; METALS; NEUROPROTECTIVE AGENTS; NUCLEIC ACIDS; OXIDATIVE STRESS; PROTEINS; REACTIVE OXYGEN SPECIES; RECEPTORS, CELL SURFACE;

EID: 0034672942     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(00)00015-0     Document Type: Review

References (191)

1. Aksenov M.Y., Tucker H.M., Nair P., Aksenova M.V., Butterfield D.A., Estus S., Markesbery W.R. The expression of key oxidative stress-handling genes in different brain regions in Alzheimer's disease. J. Mol. Neurosci. 11:1998;151-164.
2. Alvarez A., Alarcón R., Opazo C., Campos E.O., Muñoz F.J., Calderón F.H., Dajas F., Gentry M.K., Doctor B.P., De Mello F.G., Inestrosa N.C. Stable complexes involving acetylcholinesterase and amyloid-β peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils. J. Neurosci. 18:1998;3213-3223.
3. Andersen K., Launer L.J., Ott A., Hoes A.W., Breteler M.M., Hofman A. Do non-steroidal anti-inflamatory drugs decrease the risk for Alzheimer's disease? The Rotterdam study. Neurology. 45:1995;1441-1445.
4. Ard M.D., Cole G.M., Wei J., Mehrle A.P., Fratkin J.D. Scavenging of Alzheimer's amyloid β-protein by microglia in culture. J. Neurosci. Res. 43:1996;190-202.
5. Armstrong R.A. A comparison of β-amyloid deposition in the medial temporal lobe in late-onset sporadic Alzheimer's disease and Down's syndrome. Amyloid. 2:1995;107-113.
6. Atwood C.S., Moir R.D., Huang X., Scarpa R.C., Bacarra N.M., Romano D.M., Hartshorn M.A., Tanzi R.E., Bush A.I. Dramatic aggregation of Alzheimer Aβ by Cu(II) is induced by conditions representing physiological acidosis. J. Biol. Chem. 273:1998;12817-12826.
7. Applegate L.A., Luscher P., Tyrrell R.M. Induction of heme oxygenase: a general response to oxidant stress in cultured mammalian cells. Cancer Res. 51:1991;974-978.
8. Behl C., Davis J., Cole G.M., Schubert D. Vitamin E protects nerve cells from amyloid β protein toxicity. Biochem. Biophys. Res. Commun. 186:1992;944-950.
9. Behl C., Davis J.B., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid β protein toxicity. Cell. 77:1994;817-827.
10. Behl C., Davis J.B., Klier F.G., Schubert D. Amyloid-β-peptide induces necrosis rather than apoptosis. Brain Res. 645:1994;253-264.
11. Behl C., Widman M.T., Holsboer F. 17-β-estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem. Biophys. Res. Commun. 216:1995;473-478.
12. Behl C., Skutella T., Lezoualc'h F., Post A., Widmann M., Newton C.J., Holsboer F. Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol. Pharmacol. 51:1997;535-541.
13. Behl C. Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches. Prog. Neurobiol. 57:1999;301-323.
14. Bergeron C., Petrunka C., Weyer L. Copper/zinc superoxide dismutase expression in the human central nervous system. Correlation with selective neuronal vulnerability. Am. J. Pathol. 148:1996;273-279.
15. Beyer C.E., Steketee J.D., Saphier D. Antioxidant properties of melatonin: an emerging mystery. Biochem. Pharmacol. 56:1998;1265-1272.
16. 2-macroglobulin is genetically associated with Alzheimer's disease. Nat. Genet. 19:1998;357-360.
17. Boje K.M., Arora P.K. Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res. 587:1992;250-256.
18. Boissiere F., Hunot S., Faucheux B., Duyckaerts C., Hauw J.J., Agid Y., Hirsch E.C. Nuclear translocation of NF-κβ in cholinergic neurons of patients with Alzheimer's disease. Neuroreport. 8:1997;2849-2852.
19. Bondy S.C., Guo-Ross S.X., Truong A.T. Promotion of transition metal-induced reactive oxygen species formation by β-amyloid. Brain Res. 799:1998;91-96.
20. Bonnefont A.B., Muñoz F.J., Inestrosa N.C. Estrogen protects neuronal cells from the cytotoxicity induced by acetylcholinesterase-amyloid complexes. FEBS Lett. 441:1998;220-224.
21. Bowling A.C., Mutisya E.M., Walker L.C., Price D.L., Cork L.C., Beal M.F. Age-dependent impairment of mitochondrial function in primate brain. J. Neurochem. 60:1993;1964-1967.
22. Bozner P., Grishko V., LeDoux S.P., Wilson G.L., Chyan Y.C., Pappolla M.A. The amyloid-β-protein induces oxidative damage of mitochondrial DNA. J. Neuropathol. Exp. Neurol. 56:1997;1356-1362.
23. Braughler J.M., Pregenzer J.F. The 21-aminosteroid inhibitors of lipid peroxidation: reaction with lipid peroxyl and phenoxy radicals. Free Rad. Biol. Med. 7:1989;125-130.
24. Brusco L.I., Marquez M., Cardinali D.P. Monozygotic twins with Alzheimer's disease treated with melatonin: case report. J. Pineal Res. 25:1998;260-263.
25. Busciglio J., Yankner B.A. Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature. 378:1995;776-779.
26. Butterfield D.A., Hensley K., Cole P., Subramaniam R., Aksenov M., Aksenova M., Brummer P.M., Haley B.E., Carney J.M. Oxidatively induced structural alteration of glutamine synthetase assessed by analysis of spin label incorporation kinetics: relevance to Alzheimer's disease. J. Neurochem. 68:1997;2451-2457.
27. 25-35 fragment, glutamate, and hydrogen peroxide. J. Neurosci. Res. 56:1999;620-631.
28. Castagne V., Gautschi M., Lefevre K., Posada A., Clarke P.G. Relationships between neuronal death and the cellular redox status. Focus on the developing nervous system. Prog. Neurobiol. 59:1999;397-423.
29. Chandrasekaran K., Giordano T., Brady D.R., Stoll J., Martin L.J., Rapoport S.I. Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer's disease. Mol. Brain Res. 24:1994;336-340.
30. Chandrasekaran K., Hatanpaa K., Rapoport S.I., Brady D.R. Decreased expression of nuclear and mitochondrial DNA-encoded genes of oxidative phosphorylation in association neocortex in Alzheimer's disease. Mol. Brain Res. 44:1997;99-104.
31. Christie R.H., Freeman M., Hyman B.T. Expression of the macrophage scavenger receptor, a multifunctional lipoprotein receptor, in microglia associated with senile plaques in Alzheimer's disease. Am. J. Pathol. 148:1996;399-403.
32. Colton C.A., Gilbert D.L. Production of superoxide anions by CNS macrophage, the microglia. FEBS Lett. 223:1987;284-288.
33. Colton C.A., Snell J., Chernyshev O., Gilbert D.L. Induction of superoxide anion and nitric oxide production in cultured microglia. Ann. NY Acad. Sci. 738:1994;54-63.
34. Connor J.R., Snyder B.S., Beard J.L., Fine R.E., Mufson E.J. Regional distribution of iron and iron regulatory proteins in the brain in aging and Alzheimer's disease. J. Neurosci. Res. 31:1992;327-335.
35. Curti D., Rognoni F., Gasparini L., Cattaneo A., Paolillo M., Racchi M., Zani L., Bianchetti A., Trabucchi M., Bergamaschi S., Govoni S. Oxidative metabolism in cultured fibroblasts derived from sporadic Alzheimer's disease (AD) patients. Neurosci. Lett. 236:1997;13-16.
36. Daniels W.M., van Rensburg S.J., van Zyl J.M., Taljaard J.J. Melatonin prevents β-amyloid-induced lipid peroxidation. J. Pineal Res. 24:1998;78-82.
37. Davis D.R., Anderton B.H., Brion J.P., Reynolds C.H., Hanger D.P. Oxidative stress induces dephosphorylation of tau in rat brain primary neuronal cultures. J. Neurochem. 68:1997;1590-1597.
38. 2 forming NADPH oxidase in microglia, monocytes, and neutrophils. A possible inflamatory mechanism of neuronal damage in Alzheimer's disease. J. Biol. Chem. 274:1999;15493-15499.
39. Dickson D.W., Farlo J.F., Davies P., Crystal H., Fuld P., Yen S.H. Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques. Am. J. Pathol. 132:1988;86-101.
40. Dikalov S.I., Vitek M.P., Maples K.R., Mason R.P. Amyloid peptides do not form peptide-derived free radicals spontaneously, but can enhance metal-catalyzed oxidation of hydroxylamines to nitroxides. J. Biol. Chem. 274:1999;9392-9399.
41. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood. 87:1996;2095-2147.
42. Duara R., Grady C., Haxby J., Sundaram M., Cutler N.R., Heston L., Moore A., Schlageter N., Larson S., Rapoport S.I. Positron emission tomography in Alzheimer's disease. Neurology. 36:1986;879-887.
43. Dyrks T., Dyrks E., Hartmann T., Masters C., Beyreuter K. Amyloidogenicity of βA4 and βA4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. J. Biol. Chem. 267:1992;18210-18217.
44. El Khoury J., Hickman S.E., Thomas C.A., Cao L., Silverstein S.C., Loike J.D. Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils. Nature. 382:1996;716-719.
45. Endoh M., Kunishita T., Tabira T. No effect of anti-leprosy drugs in the prevention of Alzheimer's disease and β-amyloid neurotoxicity. J. Neurol. Sci. 165:1999;28-30.
46. Esterbauer H., Schaur R.J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11:1991;81-129.
47. Ettinger B., Friedman G.D., Bush T., Quesenberry C.P. Reduced mortality associated with long-term postmenopausal estrogen therapy. Obstet. Gynecol. 87:1996;6-12.
48. Frautschy S.A., Yang F., Irrizarry M., Hyman B., Saido T.C., Hsiao K., Cole G.M. Microglial response to amyloid plaques in APPsw transgenic mice. Am. J. Pathol. 152:1998;307-317.
49. Gabbita S.P., Lovell M.A., Markesbery W.R. Increased nuclear DNA oxidation in the brain in Alzheimer's disease. J. Neurochem. 71:1998;2034-2040.
50. Galeazzi L., Ronchi P., Franceschi C., Giunta S. In vitro peroxidase oxidation induces stable dimers of β-amyloid (1-42) through dityrosine bridge formation. Amyloid. 6:1999;7-13.
51. Gerlach M., Ben-Shachar D., Riederer P., Youdim M.B. Altered brain metabolism of iron as a cause of neurodegenerative disease? J. Neurochem. 63:1994;793-807.
52. Giem P., Beeson W.L., Fraser G.E. The incidence of dementia and intake of animal products: preliminary findings from the Adventist Health Study. Neuroepidemiology. 12:1993;28-36.
53. Giulian D. Ameboid microglia as effectors of inflamation in the central nervous system. J. Neurosci. Res. 18:1987;155-171.
54. Good P.F., Perl D.P., Bierer L.M., Schmeidler J. Selective accumulation of aluminium and iron in the neurofibrilary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study. Ann. Neurol. 31:1992;286-292.
55. Goodman Y., Steiner M.R., Steiner S.M., Mattson M.P. Nordihydroguaiaretic acid protects hippocampal neurons against amyloid β-peptide toxicity, and attenuates free radical and calcium accumulation. Brain Res. 654:1994;171-176.
56. Goodman Y., Bruce A.J., Cheng B., Mattson M.P. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid β-peptide toxicity in hippocampal neurons. J. Neurochem. 66:1996;1836-1844.
57. Griffin W.S., Stanley L.C., Ling C., White L., MacLeod V., Perrot L.J., White C.L., Araoz C. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down's syndrome and Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 86:1989;7611-7615.
58. Gsell W., Conrad R., Hickethier M., Sofic E., Frlich L., Wichart I., Jellinger K., Moll G., Ransmayr G., Beckmann H., Riederer P. Decreased catalase activity but unchanged superoxide dismutase activity in brains of patients with dementia of Alzheimer type. J. Neurochem. 64:1995;1216-1223.
59. Guo Q., Sopher B.L., Furukawa K., Pham D.G., Robinson N., Martin G.M., Mattson M.P. Alzheimer's presenilin mutation sensitizes neuronal cells to apoptosis induced by trophic factor withdrawal and amyloid β-peptide: involvement of calcium and oxyradicals. J. Neurosci. 17:1997;4212-4222.
60. Haass C. Presenilins: genes for life and death. Neuron. 18:1997;687-690.
61. Hass C., De Strooper B. The presenilins in Alzheimer's disease-proteolysis holds the key. Science. 286:1999;916-919.
62. Hall E.D., Pazara K.E., Linseman K.L. Sex differences in post-ischemic neuronal necrosis in gerbils. J. Cereb. Blood Flow Metab. 11:1991;292-298.
63. Halliwell B., Gutteridge J.M. Lipid peroxidation, oxygen radicals, cell damage, and antioxidant therapy. Lancet. 1:1984;1396-1397.
64. Harman D. A hypothesis on the pathogenesis of Alzheimer's disease. Ann. NY Acad. Sci. 786:1996;152-168.
65. Harrington C.R., Colaco C.A. Alzheimer's disease. A glycation connection. Nature. 370:1994;47-48.
66. Hensley K., Carney J.M., Mattson M.P., Aksenova M., Harris M., Wu J.F., Floyd R.A., Butterfield D.A. A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 91:1994;3270-3274.
67. Hensley K., Hall N., Subramanian R., Cole P., Harris M., Aksenov M., Aksenova M., Gabbita S.P., Wu J.F., Carney J.M., Lowell M., Markesberry W.R., Butterfield D.A. Brain regional correspondence between Alzheimer's disease (AD) histopathology and biomarkers of protein oxidation. J. Neurochem. 65:1995;2146-2156.
68. Hermon M., Cairns N., Egly J.M., Fery A., Labudova O., Lubec G. Expression of DNA excision-repair-cross-complementing proteins p80 and p89 in brain of patients with Down's syndrome and Alzheimer's disease. Neurosci. Lett. 251:1998;45-48.
69. Hockenbery D.M., Oltvai Z.N., Yin X.M., Milliman C.L., Korsmeyer S.J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell. 75:1993;241-251.
70. Hoyer S., Oesterreich K., Wagner O. Glucose metabolism as the site of the primary abnormality in early-onset dementia of Alzheimer type? J. Neurol. 235:1988;143-148.
71. Huang X., Atwood C.S., Hartshorn M.A., Multhaup G., Goldstein L.E., Scarpa R.C., Cuajungco M.P., Gray D.N., Lim J., Moir R.D., Tanzi R.E., Bush A.I. The amyloid-β-peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry. 38:1999;7609-7616.
72. Huang X., Cuajungco M.P., Atwood C.S., Hartshorn M.A., Tyndall J.D., Hanson G.R., Stokes K.C., Leopold M., Multhaup G., Goldstein L.E., Scarpa R.C., Saunders A.J., Lim J., Moir R.D., Glabe C., Bowden E.F., Masters C.L., Fairlie D.P., Tanzi R.E., Bush A.I. Cu(II) potentiation of Alzheimer Aβ neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction. J. Biol. Chem. 74:1999;37111-37116.
73. Hurst J.K., Barrette W.C. Leukocytic oxygen activation and microbicidal oxidative toxins. Crit. Rev. Biochem. Mol. Biol. 24:1989;271-328.
74. Inestrosa N.C., Reyes A.E. Acetylcholinesterase induces amyloid formation and increases neurotoxicity of Alzheimer's fibrils. Neurobiol. Aging. 19:(Suppl 4):1998;S44.
75. Inestrosa N.C., Marzolo M.P., Bonnefont A.B. Cellular and molecular basis of estrogen's neuroprotection. Potential relevance for Alzheimer's disease. Mol. Neurobiol. 17:1998;73-86.
76. Inestrosa, N.C., Larrondo, L.F., 2000. Oxidative stress in Alzheimer's disease. In: Leighton, F., Urquiaga, I. (Eds.), Health, Antioxidants and Ageing, Vicerectory of Catholic University of Chile, Santiago, Chile.
77. Itagaki S., McGeer P.L., Akiyama H. Presence of T-cytotoxic suppressor and leukocyte common antigen positive cells in Alzheimer's disease brain tissue. Neurosci. Lett. 91:1988;259-264.
78. Jaffe A.B., Torand-Allerand C.D., Greengard P., Gandy S.E. Estrogen regulates metabolism of Alzheimer amyloid-β-precursor protein. J. Biol. Chem. 269:1994;13065-13068.
79. Jeandel C., Nicholas M.B., DuBois F., Nabet-Belleville F., Penin F., Cuny G. Lipid peroxidation and free radical scavengers in Alzheimer's disease. Gerontology. 35:1989;275-282.
80. Joseph J.A., Shukitt-Hale B., Denisova N.A., Bielinski D., Martin A., McEwen J.J., Bickford P.C. Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation. J. Neurosci. 19:1999;8114-8121.
81. Kala S.V., Hasinoff B.B., Richardson J.S. Brain samples from Alzheimer's patients have elevated levels of loosely bound iron. Int. J. Neurosci. 86:1996;263-269.
82. Kalaria R.N., Harik S.I. Reduced glucose transporter at the blood-brain barrier and in cerebral cortex in Alzheimer's disease. J. Neurochem. 53:1989;1083-1088.
83. Kaltschmidt B., Uherek M., Volk B., Baeuerle P.A., Kaltschmidt C. Transcription factor NF-κβ is activated in primary neurons by amyloid-β-peptides and in neurons surrounding early plaques from patients with Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 94:1997;2642-2647.
84. Kane D.J., Sarafian T.A., Anton R., Hahn H., Gralla E.B., Valentine J.S., Ord T., Bredesen D.E. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science. 262:1993;1274-1277.
85. Kang D.E., Saitoh T., Chen X., Xia Y., Masliah E., Hansen L.A., Thomas R.G., Thal L.J., Katzman R. Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease. Neurology. 49:1997;56-61.
86. Keller J.N., Pang Z., Geddes J.W., Begley J.G., Germeyer A., Waeg G., Mattson M.P. Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid β-peptide: role of the lipid peroxidation product 4-hydroxynonenal. J. Neurochem. 69:1997;273-284.
87. +-ATPase activity, glucose transport, and glutamate transport induced by amyloid β-peptide and iron. J. Neurosci. Res. 50:1997;522-530.
88. Kelly J.F., Furukawa K., Barger S.W., Rengen M.R., Mark R.J., Blanc E.M., Roth G.S., Mattson M.P. Amyloid β-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons. Proc. Natl. Acad. Sci. USA. 93:1996;6753-6758.
89. Kitamura Y., Shimohama S., Ota T., Matsuoka Y., Nomura Y., Taniguchi T. Alteration of transcription factors NF-κβ and STAT1 in Alzheimer's disease brains. Neurosci. Lett. 237:1997;17-20.
90. Klegeris A., Walker D.G., McGeer P.L. Activation of macrophages by Alzheimer β-amyloid peptide. Biochem. Biophys. Res. Commun. 199:1994;984-991.
91. Knauer M.F., Orlando R.A., Glabe C.G. Cell surface APP751 forms complexes with protease nexin 2 ligands and is internalized via the low density lipoprotein receptor-related protein (LRP). Brain Res. 740:1996;6-14.
92. Koppal T., Subramaniam R., Drake J., Prasad M.R., Dhillon H., Butterfield D.A. Vitamin E protects against Alzheimer's amyloid peptide-(25-35) induced changes in neocortical synaptosomal membrane lipid structure and composition. Brain Res. 786:1998;270-273.
93. Kruman I., Bruce-Keller A.J., Bredesen D., Waeg G., Mattson M.P. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J. Neurosci. 17:1997;5089-5100.
94. Lemeshow S., Letenneur L., Dartigues J.F., Lafont S., Orgogozo J.M., Commenges D. Illustration of analysis taking into account complex survey considerations: the association between wine consumption and dementia in the PAQUID study. Personnes Ages Quid. Am. J. Epidemiol. 148:1998;298-306.
95. Lezoualc'h F., Sparapani M., Behl C. N-acetyl-serotonin (normelatonin) and melatonin protect neurons against oxidative challenges and suppress the activity of the transcription factor NF-κβ J. Pineal Res. 24:1998;168-178.
96. Lin F.H., Lin R., Wisniewski H.M., Hwang Y.W., Grundke-Iqbal I., Healy-Louie G., Iqbal K. Detection of point mutations in codon 331 of mitochondrial NADH dehydrogenase subunit 2 in Alzheimer's brains. Biochem. Biophys. Res. Commun. 128:1992;238-246.
97. Liu Y., Dargusch R., Schubert D. β-amyloid toxicity does not require RAGE protein. Biochem. Biophys. Res. Commun. 237:1997;37-40.
98. Liu R.Y., Zhou J.N., van Heerikhuize J., Hofman M.A., Swaab D.F. Decreased melatonin levels in postmorten cerebrospinal fluid in relation to aging, Alzheimer's disease, and apolipoprotein E-epsilon4/4 genotype. J. Clin. Endocrinol. Metab. 84:1999;323-327.
99. Loo D.T., Copani A., Pike C.J., Whittemore E.R., Walencewicz A.J., Cotman C.W. Apoptosis is induced by β-amyloid in cultured central nervous system neurons. Proc. Natl. Acad. Sci. USA. 90:1993;7951-7955.
100. Lovell M.A., Ehmann W.D., Butler S.M., Markesbery W.R. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology. 45:1995;1594-1601.
101. Lovell M.A., Ehmann W.D., Mattson M.P., Markesbery W.R. Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease. Neurobiol. Aging. 18:1997;457-461.
102. Lovell M.A., Robertson J.D., Teesdale W.J., Campbell J.L., Markesbery W.R. Copper, iron and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. 158:1998;47-52.
103. Lovell M.A., Gabbita S.P., Markesbery W.R. Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF. J. Neurochem. 72:1999;771-776.
104. Mantyh P.W., Ghilardi J.R., Rogers S., DeMaster E., Allen C.J., Stimson E.R., Maggio J.E. Aluminum, iron and zinc ions promote aggregation of physiological concentrations of β-amyloid peptide. J. Neurochem. 61:1993;1171-1174.
105. Marcus D.L., Thomas C., Rodriguez C., Simberkoff K., Tsai J.S., Strafaci J.A., Freedman M.L. Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease. Exp. Neurol. 150:1998;40-44.
106. 2+ homeostasis and cell death. J. Neurosci. 15:1995;6239-6249.
107. Mark R.J., Lovell M.A., Markesbery W.R., Uchida K., Mattson M.P. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid β-peptide. J. Neurochem. 68:1997;255-264.
108. Mark R.J., Fuson K.S., May P.C. Characterization of 8-epiprostaglandin F2α as a marker of amyloid β-peptide-induced oxidative damage. J. Neurochem. 72:1999;1146-1153.
109. Martins R.N., Harper C.G., Stokes G.B., Masters C.L. Increased cerebral glucose-6-phosphate dehydrogenase activity in Alzheimer's disease may reflect oxidative stress. J. Neurochem. 46:1986;1042-1045.
110. 2-macroglobulin receptor/low density lipoprotein receptor-related protein (LRP) in rat microglial cells. J. Neurosci. Res. 60, 401-411.
111. Marzolo M.P., von Bernhardi R., Inestrosa N.C. Mannose receptor is present in a functional state in rat microglial cells. J. Neurosci. Res. 58:1999;387-395.
112. Mattson M.P. Cellular actions of β-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol. Rev. 77:1997;1081-1132.
113. Mattson M.P., Goodman Y., Luo H., Fu W., Furukawa K. Activation of NF-κβ protects hippocampal neurons against oxidative stress-induced apoptosis: evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration. J. Neurosci. Res. 49:1997;681-697.
114. Maurizi C.P. Loss of intraventricular fluid melatonin can explain the neuropathology of Alzheimer's disease. Med. Hypotheses. 49:1997;153-158.
115. Mecocci P.L., MacGarvey U., Beal M.F. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann. Neurol. 36:1994;747-750.
116. Meda L., Cassatella M.A., Szendrei G., Otvos L., Baron P., Villalba M., Ferrari D., Rossi F. Activation of microglial cells by Aβ protein and interferon-γ Nature. 374:1995;647-650.
117. McGeer P.L., Itagaki S., Tago H., McGeer E.G. Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci. Lett. 79:1987;195-200.
118. McGeer P.L., Rogers J. Anti-inflamatory agents as therapeutic approach to Alzheimer's disease. Neurology. 42:1992;447-448.
119. Miranda S., Foncea R., Guerrero J., Leighton F. Oxidative stress and upregulation of mitochondrial biogenesis genes in mitochondrial DNA depleted HeLa cells. Biochem. Biophys. Res. Commun. 258:1999;44-49.
120. Montine T.J., Amarnath V., Martin M.E., Strittmatter W.J., Graham D.G. E-4-hydroxy-2-nonenal is cytotoxic and cross-links cytoskeletal proteins in P19 neuroglial cultures. Am. J. Pathol. 148:1996;89-93.
121. Mukai K., Daifufu K., Yokoyama S. Stopped-flow investigation of antioxidant activity of estrogen in solution. Biochem. Biophys. Acta. 1035:1990;348-352.
122. Multhaup G., Schlicksupp A., Hess L., Beher D., Ruppert T., Masters C.L., Beyreuther K. The amyloid precursor protein of Alzheimer's disease in the reduction of copper (II) to copper (I). Science. 271:1996;1406-1409.
123. Multhaup G., Ruppert T., Schlicksupp A., Hesse L., Beher D., Masters C.L., Beyreuther K. Reactive oxygen species and Alzheimer's disease. Biochem. Pharmacol. 54:1997;533-539.
124. Multhaup G., Ruppert T., Schlicksupp A., Hess L., Bill E., Pipkorn R., Masters C.L., Beyreuther K. Copper-binding amyloid precursor protein undergoes a site-specific fragmentation in the reduction of hydrogen peroxide. Biochemistry. 37:1998;7224-7230.
125. Münch G., Thome J., Foley P., Schinzel R., Riederer P. Advanced glycation end products in ageing and Alzheimer's disease. Brain. Res. Rev. 23:1997;134-143.
126. Münch G., Mayer S., Michaelis J., Hipkiss A.R., Riederer P., Muller R., Neumann A., Schinzel R., Cunningham M. Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of β-amyloid peptide. Biochim. Biophys. Acta. 1360:1997;17-29.
127. Muñoz F.J., Inestrosa N.C. Neurotoxicity of acetylcholinesterase-amyloid-β-peptide aggregates is dependent on the type of Aβ-peptide and the AChE concentration present in the complexes. FEBS Lett. 450:1999;205-209.
128. Naiki H., Hasegawa K., Yamaguchi I., Nakamura H., Gejyo F., Nakakuki K. Apolipoprotein E and antioxidants have different mechanism of inhibiting Alzheimer's β-amyloid fibril formation in vitro. Biochemistry. 37:1998;17882-17889.
129. Nunomura A., Perry G., Pappolla M.A., Wade R., Hirai K., Chiba S., Smith M.A. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J. Neurosci. 19:1999;1959-1964.
130. Opazo, C., Ruiz, F.H., Inestrosa, N.C., 2000. Amyloid-β-peptide reduces copper (II) to copper (I) independent of its aggregation state. Biol. Res., in press.
131. Orgogozo J.M., Dartigues J.F., Lafont S., Letenneur L., Commenges D., Salamon R., Renaud S., Breteler M.B. Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. Rev. Neurol. (Paris). 153:1997;185-192.
132. Otterbein L.E., Kolls J.K., Mantell L.L., Cook J.L., Alam J., Choi A.M.K. Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury. J. Clin. Invest. 103:1999;1047-1054.
133. Paganini-Hill A., Henderson V.W. Estrogen replacement therapy and risk of Alzheimer's disease. Arch. Intern. Med. 156:1996;2213-2217.
134. Pappolla M.A., Omar R.A., Kim K.S., Robakis N.K. Immunohistochemical evidence of oxidative (corrected) stress in Alzheimer's disease. Am. J. Pathol. 140:1992;621-628.
135. Pappolla M.A., Sos M., Omar R.A., Bick R.J., Hickson-Bick D.L., Reiter R.J., Efthimiopoulos S., Robakis N.K. Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide. J. Neurosci. 17:1997;1683-1690.
136. Pappolla M., Bozner P., Soto C., Shao H., Robakis N.K., Zagorski M., Frangione B., Ghiso J. Inhibition of Alzheimer β-fibrillogenesis by melatonin. J. Biol. Chem. 273:1998;7185-7188.
137. Paradis E., Douillard H., Koutroumanis M., Goodyer C., LeBlanc A. Amyloid-β-peptide of Alzheimer's disease downregulates Bcl-2 and upregulates bax expression in human neurons. J. Neurosci. 16:1996;7533-7539.
138. Paresce D.M., Ghosh R.N., Maxfield F.R. Microglial cell internalize aggregates of Alzheimer's disease amyloid β-protein via a scavenger receptor. Neuron. 17:1996;553-565.
139. Parker W.D., Parks J.K. Cytochrome c oxidase deficiency in Alzheimer's disease brain: purification and characterization. Neurology. 45:1995;482-486.
140. Perlmutter L.S., Barron E., Chui H.C. Morphologic association between microglia and senile plaque amyloid in Alzheimer's disease. Neurosci. Lett. 119:1990;32-36.
141. Qin Z., Wang Y., Nakal M., Chase T.N. Nuclear factor NF-κB contributes to excitoxin-induced apoptosis in rat striatum. Mol. Pharmacol. 53:1998;33-42.
142. Reiter R.J., Carneiro R.C., Oh C.S. Melatonin in relation to cellular antioxidative defense mechanisms. Horm. Metab. Res. 29:1997;363-372.
143. Reiter R.J. Oxidative damage in the central nervous system: protection by melatonin. Prog. Neurobiol. 56:1998;359-384.
144. Reyes, A.E., Chacón, M.A., Wallem, P., Inestrosa, N.C., 2000. Intracerebral injection of acetylcholinesterase-β-amyloid complexes induces neuropathological changes as well as spatial memory impairment in rats. Eur. J. Neurosci., in press.
145. Rich J.B., Rasmusson D.X., Folstein M.F., Carson K.A., Kawas C., Brandt J. Nonsteroidal anti-inflamatory drugs in Alzheimer's disease. Neurology. 45:1995;51-55.
146. Richardson J.S. Free radicals in the genesis of Alzheimer's disease. Ann. NY Acad. Sci. 695:1993;73-76.
147. Rogers J., Cooper N.R., Webster S., Schultz J., McGeer P.L., Styren S.D., Civin W.H., Brachova L., Bradt B., Ward P., Lieberburg I. Complement activation by Aβ in Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 89:1992;10016-10020.
148. Rogers J., Kirby L.C., Hempelman S.R., Berry D.L., McGeer P.L., Kaszniak A.W., Zalinski J., Cofield M., Mansukhani L., Wilson P., Kogan F. Clinical trial of indomethacin in Alzheimer's disease. Neurology. 43:1993;1609-1611.
149. Rogers J.T., Leiter L.M., McPhee J., Cahill C.M., Zhan S.S., Potter H., Nilsson L.N. Translation of the Alzheimer amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5′-untranslated region sequences. J. Biol. Chem. 274:1999;6421-6431.
150. Rozemuller J.M., Stam F.C., Eikelenboom P. Acute phase proteins are present in the cerebral but not in the cerebellar cortex of patients with Alzheimer's disease. Neurosci. Lett. 119:1990;75-78.
151. Ruiz F.H., Gonzalez M., Bodini M., Opazo C., Inestrosa N.C. Cysteine 144 is a key residue in the copper reduction by the β-amyloid precursor protein. J. Neurochem. 73:1999;1288-1292.
152. Saitoh T., Sundsmo M., Roch J.M., Kimura N., Cole G., Schubert D., Oltersdorf T., Schenk D.B. Secreted form of amyloid-β-protein precursor is involved in the growth regulation of fibroblasts. Cell. 58:1989;615-622.
153. Sano M., Ernesto C., Thomas R.G., Klauber M.R., Schafer K., Grundman M., Woodbury P., Growdon J., Cotman C.W., Pfeiffer E., Schneider L.S., Thal L.J. A controlled trial of selegiline, α-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's disease cooperative study. N. Engl. J. Med. 336:1997;1216-1222.
154. Sawada H., Ibi M., Kihara T., Urushitani M., Akaike A., Shimohama S. Estradiol protects mesencephalic dopaminergic neurons from oxidative stress-induced neuronal death. J. Neurosci. Res. 54:1998;707-719.
155. Sayre L.M., Zelasko D.A., Harris P.L., Perry G., Salomon R.G., Smith M.A. 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J. Neurochem. 68:1997;2092-2097.
156. Sayre L.M., Perry G., Smith M.A. Redox metals and neurodegenerative disease. Curr. Opin. Chem. Biol. 3:1999;220-225.
157. Schubert D., Behl C., Lesley R., Brack A., Dargusch R., Sagara Y., Kimura H. Amyloid peptides are toxic via a common oxidative mechanism. Proc. Natl. Acad. Sci. USA. 92:1995;1989-1993.
158. Selkoe D.J. Amyloid-β-protein and the genetics of Alzheimer's disease. J. Biol. Chem. 271:1996;18295-18298.
159. Selkoe D.J. The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol. 8:1998;447-453.
160. Shaffer L.M., Dority M.D., Gupta-Bansal R., Frederickson R.C., Younkin S.G., Brunden K.R. Amyloid-β-protein removal by neuroglial cells in culture. Neurobiol. Aging. 16:1995;737-745.
161. Shearman M.S., Ragan C.I., Iversen L.L. Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of β-amyloid-mediated cell death. Proc. Natl. Acad. Sci. USA. 91:1994;1470-1474.
162. Smith M.A., Kutty R.K., Richey P.L., Yan S.D., Stern D., Chader G.J., Wiggert B., Petersen R.B., Perry G. Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. Am. J. Pathol. 145:1994;42-47.
163. Smith M.A., Perry G., Richey P.L., Sayre L.M., Anderson V.E., Beal M.F., Kowall N. Oxidative damage in Alzheimer's disease. Nature. 382:1996;120-121.
164. Smith M.A., Richey Harris P.L., Sayre L.M., Beckman J.S., Perry G. Widespread peroxynitrite-mediated damage in Alzheimer's disease. J. Neurosci. 17:1997;2653-2657.
165. Smith M.A., Hirai K., Hsiao K., Pappolla M.A., Harris P.L., Siedlak S.L., Tabaton M., Perry G. Amyloid-β deposition in Alzheimer transgenic mice is associated with oxidative stress. J. Neurochem. 70:1998;2212-2215.
166. Song W., Lahiri D.K. Melatonin alters the metabolism of the β-amyloid precursor protein in the neuroendocrine cell line PC12. J. Mol. Neurosci. 9:1997;75-92.
167. Soto C., Braens M.C., Alvarez J., Inestrosa N.C. Structural determinants of the Alzheimer's amyloid-β-peptide. J. Neurochem. 63:1994;1191-1198.
168. Soto C., Castaño E.M., Frangione B., Inestrosa N.C. The α-helical to β-strand transition in the amino-terminal fragment of the amyloid-β-peptide modulates amyloid formation. J. Biol. Chem. 270:1995;3063-3067.
169. Soto C., Sigurdsson E.M., Morelli L., Kumar R.A., Castaño E.M., Frangione B. β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy. Nat. Med. 4:1998;822-826.
170. Stadtman E.R. Metal ion-catalyzed oxidation of proteins: biochemical mechanism and biological consequences. Free Radic. Biol. Med. 9:1990;315-325.
171. Sugioka K., Shimosegawa Y., Nakano M. Estrogen as natural antioxidant of membrane phospholipid peroxidation. FEBS Lett. 210:1987;37-39.
172. Tabaton M., Perry G., Smith M., Vitek M., Angelini G., Dapino D., Garibaldi S., Zaccheo D., Odetti P. Is amyloid β-protein glycated in Alzheimer's disease? Neuroreport. 8:1997;907-909.
173. Takeda A., Kimpara T., Onodera H., Itoyama Y., Shibahara S., Kogure K. Regional diference in induction of heme oxygenase-1 protein following rat transient forebrain ischemia. Neurosci. Lett. 205:1996;169-172.
174. Tan Z., Sun N., Schreiber S.S. Inmunohistochemical localization of redox factor-1 (Ref-1) in Alzheimer's hippocampus. Neureport. 9:1998;2749-2752.
175. Tang M.X., Jacobs D., Stern Y., Marder K., Schofield P., Gurland B., Andrews H., Mayeux R. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet. 348:1996;429-432.
176. Thomas T., Thomas G., McLendon C., Sutton T., Mullan M. β-amyloid-mediated vasoactivity and vascular endothelial damage. Nature. 380:1996;168-171.
177. Tohgi H., Abe T., Takahashi S., Kimura M., Takahashi J., Kikuchi T. Concentrations of serotonin and its related substances in the cerebrospinal fluid in patients with Alzheimer type dementia. Neurosci. Lett. 141:1992;9-12.
178. Tomiyama T., Asano S., Suwa Y., Morita T., Kataoka K., Mori H., Endo N. Rifampicin prevents the aggregation and neurotoxicity of amyloid β protein in vitro. Biochem. Biophys. Res. Commun. 204:1994;76-83.
179. Tomiyama T., Shoji A., Kataoka K., Suwa Y., Asano S., Kaneko H., Endo N. Inhibition of amyloid-β-protein aggregation and neurotoxicity by rifampicin. Its possible function as a hydroxyl radical scavenger. J. Biol. Chem. 271:1996;6839-6844.
180. Vickers J.C., Dickson T.C., Adlard P.A., Saunders H.L., King C.E., McCormack G. The cause of neuronal degeneration in Alzheimer's disease. Prog. Neurobiol. 60:2000;139-165.
181. Vitek M.P., Bhattacharya K., Glendening J.M., Stopa E., Vlassara H., Bucala R., Manogue K., Cerami A. Advanced glycation end products contribute to amyloidosis in Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 91:1994;4766-4770.
182. White A.R., Multhaup G., Maher F., Bellingham S., Camakaris J., Zheng H., Bush A.I., Beyreuther K., Masters C.L., Cappai R. The Alzheimer's disease amyloid precursor protein modulates copper-induced toxicity and oxidative stress in primary neuronal cultures. J. Neurosci. 19:1999;9170-9179.
183. Xia M.Q., Quin S.X., McNamara M., Mackay C., Hyman B.T. Interleukin-8 receptor in brain and neuritic plaques of Alzheimer's disease. Am. J. Pathol. 150:1997;1267-1274.
184. Xia M.Q., Quin S.X., Wu L.J., Mackay C.R., Hyman B.T. Immunohistochemical study of the β-chemokine receptors CCR3 and CCR5 and their ligands in normal and Alzheimer's disease brain. Am. J. Pathol. 153:1998;31-37.
185. Xu H., Gouras G.K., Greenfield J.P., Vincent B., Naslund J., Mazzarelli L., Fried G., Jovanovic J.N., Seeger M., Relkin N.R., Liao F., Checler F., Buxbaum J.D., Chait B.T., Thinakaran G., Sisodia S.S., Wang R., Greengard P., Gandy S. Estrogen reduces neuronal generation of Alzheimer β-amyloid peptides. Nat. Med. 4:1998;447-451.
186. Yamada K., Tanaka T., Han D., Senzaki K., Kameyama T., Nabeshima T. Protective effects of idebenone and α-tocopherol on β-amyloid-(1-42)-induced learning and memory deficits in rats: implication of oxidative stress in β-amyloid-induced neurotoxicity in vivo. Eur. J. Neurosci. 11:1999;83-90.
187. Yan S.D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., Schmidt A.M. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature. 382:1996;685-691.
188. Yankner B.A. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron. 16:1996;921-932.
189. Zemlan F.P., Thienhaus O.J., Bosmann H.B. Superoxide dismutase activity in Alzheimer's disease: possible mechanism for paired helical filament formation. Brain Res. 476:1989;160-162.
190. 2 generation. J. Neurochem. 67:1996;1595-1606.
191. Zlokovic B.V., Martel C.L., Matsubara E., McComb J.G., Zheng G., McCluskey R.T., Frangione B., Ghiso J. Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer's disease amyloid-β at the blood-brain and blood-cerebrospinal fluid barriers. Proc. Natl. Acad. Sci. USA. 93:1996;4229-4234.